LLL 3348
Alternative Names: Desoris; Herbal anti-psoriasis compound LLL-3348 (Desoris) - Lupin Ltd; LL 3348; LLL-3348Latest Information Update: 18 Jun 2015
Price :
$50 *
At a glance
- Originator Lupin
- Class Antipsoriatics
- Mechanism of Action Cell modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Plaque psoriasis
Most Recent Events
- 18 Jun 2015 No recent reports on development identified - Phase-II/III for Plaque psoriasis in India (PO)
- 11 Dec 2013 Lupin completes a phase II/III trial in Plaque psoriasis in India
- 05 Apr 2011 Lupin completes enrolment in its phase IIb/III trial for Plaque psoriasis in India